Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for Stroke-Related Dysphagia
IRCT20230520058232N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pyridostigmine in dysphagia, sponsored by Kurdistan University of Medical Sciences. Started Jul 2023; status: completed.
02
Drugs
pyridostigmine
03
Conditions
dysphagia
Beyond the preview
Go deeper on IRCT20230520058232N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230520058232N1.